| pubmed-article:11182106 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11182106 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11182106 | lifeskim:mentions | umls-concept:C0035078 | lld:lifeskim |
| pubmed-article:11182106 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:11182106 | lifeskim:mentions | umls-concept:C1524003 | lld:lifeskim |
| pubmed-article:11182106 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:11182106 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11182106 | pubmed:abstractText | Atherosclerotic vascular disease is the main cause of morbidity and mortality in patients with end-stage renal disease, but the independent contribution of renal failure rather than associated risk factors is unclear. We sought to examine the relative contribution of these factors to the severity of atherosclerosis by measuring intima-medial thickness and brachial artery reactivity in uremic patients and controls. | lld:pubmed |
| pubmed-article:11182106 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11182106 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11182106 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11182106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11182106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11182106 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11182106 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11182106 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11182106 | pubmed:issn | 0002-9343 | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:JohnsonDD | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:KennedyRR | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:CassMM | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:MarwickT HTH | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:FathiRR | lld:pubmed |
| pubmed-article:11182106 | pubmed:author | pubmed-author:IsbelNN | lld:pubmed |
| pubmed-article:11182106 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11182106 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11182106 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:11182106 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11182106 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11182106 | pubmed:pagination | 198-204 | lld:pubmed |
| pubmed-article:11182106 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:meshHeading | pubmed-meshheading:11182106... | lld:pubmed |
| pubmed-article:11182106 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11182106 | pubmed:articleTitle | Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease? | lld:pubmed |
| pubmed-article:11182106 | pubmed:affiliation | University of Queensland, Brisbane, Queensland, Australia. | lld:pubmed |
| pubmed-article:11182106 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11182106 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11182106 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11182106 | lld:pubmed |
